Kaizen Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kaizen Advisory's LLY Position: Q4 2018 in Review
Kaizen Advisory increased its Eli Lilly (LLY) stake by 15% in Q4 2018, buying an estimated $39.3K and bringing the position to 2,646 shares worth $306K. The position accounts for 0.21% of the portfolio, ranked #138.
Kaizen Advisory first reported a position in LLY in Q4 2017 and has held it in 5 quarters since. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.
- Kaizen Advisory held 2,646 shares of Eli Lilly worth $306K as of Q4 2018.
- Kaizen Advisory bought 352 Eli Lilly shares in Q4 2018, an estimated $39.3K.
- Eli Lilly made up 0.21% of Kaizen Advisory's portfolio in Q4 2018, its #138 holding.
- Kaizen Advisory first reported a position in Eli Lilly in Q4 2017 and has held it in 5 quarters since.
- 1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.
Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.